These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 29588585)

  • 1. Recent developments in solid lipid nanoparticle and surface-modified solid lipid nanoparticle delivery systems for oral delivery of phyto-bioactive compounds in various chronic diseases.
    Ganesan P; Ramalingam P; Karthivashan G; Ko YT; Choi DK
    Int J Nanomedicine; 2018; 13():1569-1583. PubMed ID: 29588585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface modification of solid lipid nanoparticles for oral delivery of curcumin: Improvement of bioavailability through enhanced cellular uptake, and lymphatic uptake.
    Baek JS; Cho CW
    Eur J Pharm Biopharm; 2017 Aug; 117():132-140. PubMed ID: 28412471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced permeability of blood-brain barrier and targeting function of brain via borneol-modified chemically solid lipid nanoparticle.
    Song H; Wei M; Zhang N; Li H; Tan X; Zhang Y; Zheng W
    Int J Nanomedicine; 2018; 13():1869-1879. PubMed ID: 29636606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hansen solubility parameters (HSP) for prescreening formulation of solid lipid nanoparticles (SLN): in vitro testing of curcumin-loaded SLN in MCF-7 and BT-474 cell lines.
    Doktorovova S; Souto EB; Silva AM
    Pharm Dev Technol; 2018 Jan; 23(1):96-105. PubMed ID: 28949267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced oral delivery of curcumin from N-trimethyl chitosan surface-modified solid lipid nanoparticles: pharmacokinetic and brain distribution evaluations.
    Ramalingam P; Ko YT
    Pharm Res; 2015 Feb; 32(2):389-402. PubMed ID: 25082210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid lipid nanoparticles for oral drug delivery: chitosan coating improves stability, controlled delivery, mucoadhesion and cellular uptake.
    Luo Y; Teng Z; Li Y; Wang Q
    Carbohydr Polym; 2015 May; 122():221-9. PubMed ID: 25817662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing the oral bioavailability of curcumin using solid lipid nanoparticles.
    Ban C; Jo M; Park YH; Kim JH; Han JY; Lee KW; Kweon DH; Choi YJ
    Food Chem; 2020 Jan; 302():125328. PubMed ID: 31404868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyester-Solid Lipid Mixed Nanoparticles with Improved Stability in Gastro-Intestinal Tract Facilitated Oral Delivery of Larotaxel.
    Gou J; Feng S; Liang Y; Fang G; Zhang H; Yin T; Zhang Y; He H; Wang Y; Tang X
    Mol Pharm; 2017 Nov; 14(11):3750-3761. PubMed ID: 28945434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term stability, biocompatibility and oral delivery potential of risperidone-loaded solid lipid nanoparticles.
    Silva AC; Kumar A; Wild W; Ferreira D; Santos D; Forbes B
    Int J Pharm; 2012 Oct; 436(1-2):798-805. PubMed ID: 22867992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Core-shell microcapsules of solid lipid nanoparticles and mesoporous silica for enhanced oral delivery of curcumin.
    Kim S; Diab R; Joubert O; Canilho N; Pasc A
    Colloids Surf B Biointerfaces; 2016 Apr; 140():161-168. PubMed ID: 26752213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of solid lipid nanoparticles for sustained drug release.
    Attama AA; Umeyor CE
    Ther Deliv; 2015; 6(6):669-84. PubMed ID: 26149784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery.
    Das S; Chaudhury A
    AAPS PharmSciTech; 2011 Mar; 12(1):62-76. PubMed ID: 21174180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles.
    Yuan H; Chen CY; Chai GH; Du YZ; Hu FQ
    Mol Pharm; 2013 May; 10(5):1865-73. PubMed ID: 23495754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid functionalized long-circulating co-encapsulated docetaxel and curcumin solid lipid nanoparticles: In vitro evaluation, pharmacokinetic and biodistribution in rats.
    Pawar H; Surapaneni SK; Tikoo K; Singh C; Burman R; Gill MS; Suresh S
    Drug Deliv; 2016 May; 23(4):1453-68. PubMed ID: 26878325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of lipid nanoparticles with high loading capacity and exceptional gastrointestinal stability for potential oral delivery applications.
    Wang T; Xue J; Hu Q; Zhou M; Luo Y
    J Colloid Interface Sci; 2017 Dec; 507():119-130. PubMed ID: 28780331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactoferrin bioconjugated solid lipid nanoparticles: a new drug delivery system for potential brain targeting.
    Singh I; Swami R; Pooja D; Jeengar MK; Khan W; Sistla R
    J Drug Target; 2016; 24(3):212-23. PubMed ID: 26219519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization of solid lipid nanoparticles for enhanced delivery of curcumin in cocultures of HT29-MTX and Caco-2 cells.
    Guri A; Gülseren I; Corredig M
    Food Funct; 2013 Sep; 4(9):1410-9. PubMed ID: 23921424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel approach to oral iron delivery using ferrous sulphate loaded solid lipid nanoparticles.
    Zariwala MG; Elsaid N; Jackson TL; Corral López F; Farnaud S; Somavarapu S; Renshaw D
    Int J Pharm; 2013 Nov; 456(2):400-7. PubMed ID: 24012860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. To reduce premature drug release while ensuring burst intracellular drug release of solid lipid nanoparticle-based drug delivery system with clathrin modification.
    Li J; Sun L; Liu Y; Yao H; Jiang S; YunzhuPu ; Li Y; Zhang Y
    Nanomedicine; 2019 Jan; 15(1):108-118. PubMed ID: 29859268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicochemical characterization techniques for solid lipid nanoparticles: principles and limitations.
    Kathe N; Henriksen B; Chauhan H
    Drug Dev Ind Pharm; 2014 Dec; 40(12):1565-75. PubMed ID: 24766553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.